OTC · Medical - Pharmaceuticals

Nunzia Pharmaceutical Company (NUNZ) Stock

$0.00 OTC: NUNZ Healthcare

Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorders.

Valuation

MetricValue
Price$0.00
Market Cap$43451
P/E Ratio0.00
P/B Ratio-0.32
P/S Ratio0.00
EPS (TTM)$-0.26
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE—
ROA—
ROCE—
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-1.03
Current Ratio0.00

Annual Financials (USD)

Metric20172018201920202021
Revenue$0$0$0$0$0
Operating Profit$0$0$0$0$-78.0M
Net Profit$0$0$0$-101.0M$-78.0M
EPS$0.00$0.00$0.00$-0.35$-0.26
Op Margin—————

Balance Sheet (USD)

Metric20172018201920202021
Total Assets$0$0$0$0$0
Total Liabilities$0$0$0$0$0
Cash$0$0$0$0$0
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20172018201920202021
Operating Cash Flow$0$0$0$-9.0M$0
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$-9.0M$0
Free Cash Flow$0$0$0$-9.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.00
FCF Yield-199.71%
Quick Ratio0.00
Interest Coverage-41923.15
Return 1Y-96.67%
Return 3Y-96.67%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Nunzia Pharmaceutical Company

Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorders. It offers its products through wholesalers, as well as through its website nunziapharma.com. The company was formerly known as Arizona Gold and Onyx Mining Company and changed its name to Nunzia Pharmaceutical Company in February 2018. Nunzia Pharmaceutical Company was incorporated in 1986 and is based in Long Beach, California.

Nunzia Pharmaceutical Company (NUNZ) stock trades at $0.00 with a market capitalization of $43451. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of -0.32, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Nunzia Pharmaceutical Company generates an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.nunziapharma.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides